Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas

Determination of tumor response to treatment in neuro-oncology is challenging, particularly when antiangiogenic agents are considered. Nontumoral factors (eg, blood-brain barrier disruption, edema, and necrosis) can alter contrast enhancement independent of true tumor response/progression. Furthermo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AJNR Am J Neuroradiol
Autors principals: Jaspan, T., Morgan, P.S., Warmuth-Metz, M., Sanchez Aliaga, E., Warren, D., Calmon, R., Grill, J., Hargrave, D., Garcia, J., Zahlmann, G.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Neuroradiology 2016
Matèries:
Pediatrics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7984693/
https://ncbi.nlm.nih.gov/pubmed/27127006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A4782
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars